RIKEN Program for Drug Discovery and Medical Technology Platforms (DMP)

創薬・医療技術基盤プログラム

Japan

Time frame: 1 May 2025 - 30 April 2026

Research

RIKEN Program for Drug Discovery and Medical Technology Platforms (DMP) has the following research output in the current window (1 May 2025 - 30 April 2026) of the Nature Index. Click on Count to view a list of articles representing the corresponding Share value.

Overall research output

Count Share
Overall 1 0.04

Overall Count and Share for 'RIKEN Program for Drug Discovery and Medical Technology Platforms (DMP)' based on the 12-month time frame mentioned above.

View all articles

Research outputs by subject area

Note: Natural sciences includes biological sciences, chemistry, Earth & environmental sciences and physical sciences.
Subject Count Share
Health sciences 1 0.04

Note: Hover over the donut graph to view the Share for each subject.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Get Started
Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.

Learn more

Latest supplements

Nature Index 2026 Nanoscience and nanotechnology

From programmable RNA architectures to next-generation materials for energy and healthcare, researchers are harnessing the unusual properties of the nanoscale to tackle some of society's biggest challenges. This supplement explores the discoveries that are driving the field, the hurdles that remain and the institutions that are leading in nanoscience and nanotechnology research.

Nature Index 2026 Nanoscience and nanotechnology
Access for free

Nature Index 2026 Chemistry

Chemistry research is undergoing a period of transformation, driven by new technologies and mounting environmental pressures. In this supplement, we explore the trends behind China’s extraordinary rise in chemistry output, and why efforts to curb the use of PFASs are accelerating worldwide. We also look at the innovations that could redefine how chemicals are designed, produced and recycled.

Nature Index 2026 Chemistry
Access for free

Relationships

Affiliated institutions

The following affiliated institutions are wholly owned, operated, administered or contains research facilities for RIKEN Program for Drug Discovery and Medical Technology Platforms (DMP). All affiliations for an affiliated institution are credited to the institution to which it is affiliated. Each of the affiliated institutions listed below has its own research profile.